Keywords: thalidomide, enters, cancer, testing, program, nci, bristol-myers

Thalidomide Enters Cancer Testing Program At NCI

Article | 15 April 1996

Bristol-Myers Squibb and the US National Cancer Institute have started a clinical program to test thalidomide's anticancer effects. The program ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Thalidomide

Thalomid

Go to drug listing